Pharma News – January 2, 2020

Your weekly dose of interesting tidbits from around the pharma web…

 

Health-care stocks rose after a U.S. appeals court punted on deciding whether the Affordable Care Act is unconstitutional. The decision will likely delay Supreme Court arguments on the landmark case until after the 2020 elections, with a ruling as far out as 2021. (CNBC)

 

Hospitals, many of which are increasingly in dire financial straits, are weighing a lucrative new opportunity: selling patient health information to tech companies. (CNBC)

 

Despite bipartisan support to eliminate surprise billing, Congress has punted the issue to next year, amid competing congressional proposals and pushback from doctors, hospitals and insurers. (Healthcaredive)

 

The end of a health insurance fee will eliminate more than $15 billion in taxes that were expected to be levied on insurers including big players like Anthem, Cigna, Humana and UnitedHealth Group. The end of the so-called “HIF” is an election-year gift to the health insurance industry, which has for years been fighting to put off or get Congress and the White House to repeal the fee, which was part of the Affordable Care Act. (Forbes)

 

The out-of-pocket costs for out-of-network (OON) care grew rapidly for privately insured Americans from 2012 to 2017, according to a study published in the December issue of the American Journal of Managed Care. (Drugs)

 

Building meaningful relationships with HCPs is key to pharmaceutical sales success, and so it’s crucial for medcomm agencies. Check out our latest blog “Increasing HCP Engagement Through Speaker Program Technology” for some helpful tips on how you can start using speaker program technology to increase engagement with HCPs and pharma for better program ROI.

 

–  To find out more about Pharmagin, Contact Us  –

 

 

en_USEnglish
en_USEnglish